Pancytopenia: all 62 studies

Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• Clinical, Hematological and Pathological Profile of PancytopeniaNot yet recruitingNCT07785726
• A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure SyndromesNot yet recruitingNCT07712562Phase 1/2
• Shwachman-Diamond Syndrome Global Patient Survey and Partnering PlatformRecruitingNCT06999954
• CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System DiseasesRecruitingNCT06787560Early Phase 1
• REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2Not yet recruitingNCT06607367Phase 1/2
• European Rare Blood Disorders Platform (ENROL)RecruitingNCT06250595
• Rollover Study From EXG-US-01Enrolling by invitationNCT05868499Phase 1
• Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure DiseaseRecruitingNCT05823376
• Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure DisordersRecruitingNCT05794425Phase 1/2
• Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure SyndromesRecruitingNCT05436587
• Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)RecruitingNCT05196789
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell TransplantationCompletedNCT03513328Phase 1/2Results posted
• Eltrombopag for Fanconi AnemiaActive, not recruitingNCT03206086Phase 2Results posted
• NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic AnemiaCompletedNCT02833805Phase 2Results posted
• Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable DiseasesCompletedNCT02277639Phase 2Results posted
• Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant DiseasesTerminatedNCT02231710Phase 1Results posted
• Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic AnemiaCompletedNCT02224872Phase 2Results posted
• CD34+ Stem Cell Infusion to Augment Graft FunctionTerminatedNCT01856582Phase 2Results posted
• Eltrombopag With Standard Immunosuppression for Severe Aplastic AnemiaActive, not recruitingNCT01623167Phase 1/2Results posted
• Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell TransplantationTerminatedNCT01596699Phase 2Results posted
• Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic AnemiaCompletedNCT01193283Phase 1/2Results posted
• A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic AnemiaCompletedNCT01187017Phase 1/2Results posted
• T-cell Depleted Alternative Donor TransplantationTerminatedNCT00968864Phase 2Results posted
• Sirolimus for Autoimmune Disease of Blood CellsCompletedNCT00392951Phase 1/2Results posted
• Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
• G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure SyndromeTerminatedNCT00228813Not applicableResults posted
• Stem Cell Transplant for Bone Marrow Failure SyndromesCompletedNCT00176878Phase 2/3Results posted
• Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure SyndromesCompletedNCT00004143Phase 2Results posted
• MNCs for Bone Marrow Failure After Malignant Diseases Children ChemotherapyStatus unknownNCT05628272Not applicable
• Spectrum of Hematological Disorders in PediatricsStatus unknownNCT05473650
• The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders.Status unknownNCT04819607
• Pancytopenia Related to PARP Inhibitors (PancytoRIB)CompletedNCT04774627
• Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy PatientsCompletedNCT04723706
• TPO-Mimetic Use in Children for Hematopoietic FailureCompletedNCT04478227Early Phase 1
• Severe Immune Cytopenia Registry Www.Sic-reg.OrgCompletedNCT03576742
• Management of Childhood PancytopeniaStatus unknownNCT03521947
• Observational of PNH Type Cells in Korean Patients With Bone Marrow Failure Syndrome and Having Hemolytic PNHCompletedNCT03460301
• Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord TraumaWithdrawnNCT03249129
• Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot StudyWithdrawnNCT03086252Not applicable
• The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient PopulationStatus unknownNCT02393508Phase 3
• Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell TransplantationCompletedNCT02337595Phase 1/2
• Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALLCompletedNCT02314273Phase 4
• Nandrolone Decanoate in the Treatment of TelomeropathiesCompletedNCT02055456Phase 1/2
• Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)Status unknownNCT01760096Phase 2
• Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood TransplantationStatus unknownNCT01757145Phase 2
• Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal HemoglobinuriaStatus unknownNCT01642979Phase 2
• Trial of Haploidentical Stem Cell Transplantation for Haematological CancersCompletedNCT01597219Phase 2
• Phase I/II Pilot Study of Mixed Chimerism to Treat HemoglobinopathiesWithdrawnNCT01419704Phase 1/2
• Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantNo longer availableNCT01200017
• Peripheral Blood Stem Cell Transplantation Using the CliniMACS DeviceCompletedNCT01071226Not applicable
• Unrelated Donor Transplant for Malignant and Non-Malignant DisordersTerminatedNCT01050439Phase 2
• CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor TransplantCompletedNCT01049854Phase 2
• Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant DiseasesCompletedNCT01019876Phase 2/3
• Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic DisordersCompletedNCT00897260Not applicable
• Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCTCompletedNCT00774527Phase 3
• Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure SyndromeCompletedNCT00731328Phase 2
• Identifying Characteristics of Bone Marrow Failure SyndromesStatus unknownNCT00315419
• Cytokine Gene Polymorphisms in Bone Marrow FailureCompletedNCT00085670
• Gene Therapy for the Treatment of Fanconi's Anemia Type CCompletedNCT00001399Phase 1
• Stem Cell Factor Medication for Aplastic AnemiaCompletedNCT00001398Phase 1
• Collection of Blood From Patients With PancytopeniaCompletedNCT00001214
• Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic DisordersCompletedNCT00000597Phase 3

← Pancytopenia overview